Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Hudson Executive Capital and Corindus Vascular Robotics Inc (CVRS)

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS): Douglas Braunstein And James Woolery’s Hudson Executive Capital filed an amended 13D.

You can check out Hudson Executive Capital’s latest holdings and filings here.

Please follow Hudson Executive Capital (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Hudson Executive Capital or update its stock holdings.

Douglas Braunstein And James Woolery
Douglas Braunstein And James Woolery
Hudson Executive Capital

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Hudson Executive Capital 0 26,861,154 0 26,861,154 26,861,154 14.2%
HEC Management GP 0 26,861,154 0 26,861,154 26,861,154 14.2%
Douglas L. Braunstein 0 26,861,154 0 26,861,154 26,861,154 14.2%
Douglas Braunstein And James Woolery
Douglas Braunstein And James Woolery
Hudson Executive Capital

Page 1 of 8 – SEC Filing








(Amendment No. 1)*



Vascular Robotics, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)


(CUSIP Number)

Michael D. Pinnisi

Hudson Executive Capital LP

570 Lexington Avenue, 35th Floor

New York, NY 10022


Copies to:

Stuart Bressman

Proskauer Rose LLP

Eleven Times Square

York, NY 10036

(212) 969-3000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

March 16, 2018

(Date of Event Which Requires Filing of this Statement)



If the filing person has
previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e),
13d-1(f) or 13d-1(g), check the following box.  ☐

Note: Schedules filed in paper format
shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be
deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the
Act (however, see the Notes).

Follow Corindus Vascular Robotics Inc.
Trade (CVRS) Now!